Teva Metoprolol Succinate 25 mg Recall for 18,780 Bottles Nationwide in 2026
Teva Pharmaceuticals is recalling 18,780 bottles of Metoprolol Succinate Extended-Release Tablets, 25 mg, distributed nationwide. The recall is due to failed dissolution specifications that could affect dosing. Patients should stop using affected bottles and contact Teva or their healthcare provider for guidance.
Product Details
Product: Metoprolol Succinate Extended-Release Tablets, 25 mg. NDCs: 45963-709-11 (100-tablet bottles) and 45963-709-96 (1000-tablet bottles). Quantity recalled: 18,780 bottles. Manufacturer: Teva Pharmaceuticals USA, Parsippany, NJ 07054. Sold nationwide as Rx-only.
The Hazard
The product failed dissolution specifications. This can cause inconsistent drug release and suboptimal blood pressure and heart rate control.
What to Do
1. Stop using the product. 2. Contact Teva Pharmaceuticals USA, Inc or your healthcare provider for guidance.
Contact Information
Official recall page: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0354-2026. Additional contact details were not provided in the notice.